Published in Immunology on December 01, 1996
The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med (2003) 2.63
Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest (1999) 2.61
Elucidation of intracellular recycling pathways leading to exocytosis of the Fc receptor, FcRn, by using multifocal plane microscopy. Proc Natl Acad Sci U S A (2007) 2.56
IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol (2011) 2.36
MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol (2001) 2.33
Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med (2002) 2.32
Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A (2000) 2.20
Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci U S A (2008) 2.12
Exocytosis of IgG as mediated by the receptor, FcRn: an analysis at the single-molecule level. Proc Natl Acad Sci U S A (2004) 2.09
Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology (1997) 1.99
IgG subclasses and allotypes: from structure to effector functions. Front Immunol (2014) 1.95
Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol (2005) 1.94
Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Res (2005) 1.88
Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model. Clin Immunol (2006) 1.81
The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity. J Cell Biol (2009) 1.68
Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin. J Biol Chem (2002) 1.58
Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn. Adv Immunol (2009) 1.42
Renal FcRn reclaims albumin but facilitates elimination of IgG. J Am Soc Nephrol (2009) 1.40
Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene. Proc Natl Acad Sci U S A (2006) 1.39
Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery. Sci Transl Med (2013) 1.38
Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor. Traffic (2006) 1.36
Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J Clin Invest (2005) 1.36
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics. Crit Rev Biotechnol (2013) 1.31
Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies. Proc Natl Acad Sci U S A (2006) 1.26
Analyses of the recycling receptor, FcRn, in live cells reveal novel pathways for lysosomal delivery. Traffic (2009) 1.24
Targeting the neonatal fc receptor for antigen delivery using engineered fc fragments. J Immunol (2008) 1.20
Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine. Pediatr Res (2003) 1.16
Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn. Protein Sci (2009) 1.12
FcRn in the yolk sac endoderm of mouse is required for IgG transport to fetus. J Immunol (2009) 1.11
Pharmacokinetics of anti-hepcidin monoclonal antibody Ab 12B9m and hepcidin in cynomolgus monkeys. AAPS J (2010) 1.10
The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bile. Immunology (2000) 1.09
A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection. J Virol (2011) 1.06
The immunologic functions of the neonatal Fc receptor for IgG. J Clin Immunol (2012) 1.06
Neonatal Fc receptor mediates internalization of Fc in transfected human endothelial cells. Mol Biol Cell (2008) 1.04
Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge. Proc Natl Acad Sci U S A (2009) 1.04
IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity. Springer Semin Immunopathol (2006) 1.02
Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge. J Virol (2013) 1.01
Investigation of the influence of FcRn on the distribution of IgG to the brain. AAPS J (2009) 1.00
Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport. Proc Natl Acad Sci U S A (2011) 0.97
beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. Am J Pathol (2003) 0.93
Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid. J Exp Med (1997) 0.91
An intracellular traffic jam: Fc receptor-mediated transport of immunoglobulin G. Curr Opin Struct Biol (2010) 0.91
Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor. J Clin Invest (2007) 0.90
The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of beta2-microglobulin association. Biochem J (2002) 0.89
Monoclonal antibodies directed against human FcRn and their applications. MAbs (2012) 0.86
Receptor-mediated endocytosis and brain delivery of therapeutic biologics. Int J Cell Biol (2013) 0.85
pH-dependent binding engineering reveals an FcRn affinity threshold that governs IgG recycling. J Biol Chem (2014) 0.85
Beta2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia. Infect Immun (2008) 0.84
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy. Adv Drug Deliv Rev (2015) 0.84
Comparison of FcRn- and pIgR-mediated transport in MDCK cells by fluorescence confocal microscopy. Traffic (2010) 0.84
Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics. Front Immunol (2015) 0.84
Inhibitors of the FcRn:IgG protein-protein interaction. AAPS J (2009) 0.83
Antibody engineering for increased potency, breadth and half-life. Curr Opin HIV AIDS (2015) 0.83
Enhanced mucosal and systemic immune responses to intestinal reovirus infection in beta2-microglobulin-deficient mice. J Virol (1997) 0.83
Role of Fc Receptors as a therapeutic target. Inflamm Allergy Drug Targets (2009) 0.83
ADME of biologics-what have we learned from small molecules? AAPS J (2012) 0.82
Pharmacokinetic models for FcRn-mediated IgG disposition. J Biomed Biotechnol (2012) 0.82
The fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of rats. J Pharmacol Exp Ther (2010) 0.81
Targeting FcRn for the modulation of antibody dynamics. Mol Immunol (2015) 0.80
Monovalent IgG4 molecules: immunoglobulin Fc mutations that result in a monomeric structure. MAbs (2013) 0.80
A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts. Mol Imaging Biol (2014) 0.80
β2-microglobulin is required for the full expression of xenobiotic-induced systemic autoimmunity. J Immunotoxicol (2011) 0.79
Predominant role of interferon-γ in the host protective effect of CD8(+) T cells against Neospora caninum infection. Sci Rep (2015) 0.78
Targeting FcRn for therapy: from live cell imaging to in vivo studies in mice. Immunol Lett (2014) 0.77
Pharmacokinetics of recombinant bifunctional fusion proteins. Expert Opin Drug Metab Toxicol (2012) 0.77
Pharmacokinetic and pharmacodynamic effects of high-dose monoclonal antibody therapy in a rat model of immune thrombocytopenia. AAPS J (2006) 0.77
Site-specific functionalization of proteins and their applications to therapeutic antibodies. Comput Struct Biotechnol J (2014) 0.77
Bovine FcRn-mediated human immunoglobulin G transfer across the milk-blood barrier in transgenic mice. PLoS One (2014) 0.76
Population pharmacokinetic modeling of LY2189102 after multiple intravenous and subcutaneous administrations. AAPS J (2014) 0.76
Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting. MAbs (2015) 0.75
Polysaccharides L900/2 and L900/3 isolated from Lactobacillus rhamnosus LOCK 0900 modulate allergic sensitization to ovalbumin in a mouse model. Microb Biotechnol (2017) 0.75
FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes. PLoS One (2015) 0.75
Investigation of the mechanism of clearance of AMG 386, a selective angiopoietin-1/2 neutralizing peptibody, in splenectomized, nephrectomized, and FcRn knockout rodent models. Pharm Res (2011) 0.75
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment. Eur J Clin Pharmacol (2015) 0.75
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives. Ther Clin Risk Manag (2015) 0.75
Systems pharmacology and enhanced pharmacodynamic models for understanding antibody-based drug action and toxicity. MAbs (2016) 0.75
Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease. J Allergy Clin Immunol (2016) 0.75
Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients. Croat Med J (2015) 0.75
Distribution of FcRn Across Species and Tissues. J Histochem Cytochem (2017) 0.75
Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature (1990) 8.57
Fc receptors. Annu Rev Immunol (1991) 7.92
Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry (1981) 6.13
Metabolism of immunoglobulins. Prog Allergy (1969) 5.74
An Fc receptor structurally related to MHC class I antigens. Nature (1989) 4.32
THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS. J Exp Med (1965) 3.87
The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci U S A (1996) 3.37
A THEORETICAL MODEL OF GAMMA-GLOBULIN CATABOLISM. Nature (1964) 3.31
The absorption of antibodies from immune sera by the gut of the young rat. Proc R Soc Lond B Biol Sci (1955) 3.27
THE IMMUNOGLOBULINS OF MICE. V. THE METABOLIC (CATABOLIC) PROPERTIES OF FIVE IMMUNOGLOBULIN CLASSES. J Exp Med (1965) 2.91
Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur J Immunol (1996) 2.90
Crystal structure of the complex of rat neonatal Fc receptor with Fc. Nature (1994) 2.85
The half-lives of serum immunoglobulins in adult mice. Eur J Immunol (1988) 2.73
Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci U S A (1992) 2.37
A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J Exp Med (1994) 2.27
pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat. J Cell Biol (1976) 2.24
Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur J Immunol (1985) 2.20
Receptor-mediated transport of IgG. J Cell Biol (1984) 2.05
Studies on receptors for IgG on epithelial cells of the rat intestine. J Immunol (1977) 1.82
Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. J Immunol (1995) 1.81
An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur J Immunol (1996) 1.74
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet (1995) 1.69
Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor. Eur J Immunol (1994) 1.57
Immunoglobulin binding by mouse intestinal epithelial cell receptors. J Immunol (1976) 1.57
Mouse MHC class I-like Fc receptor encoded outside the MHC. J Immunol (1993) 1.52
Isolation and characterization of the Fc receptor from the fetal yolk sac of the rat. J Cell Biol (1990) 1.46
High-resolution kinetics of transferrin acidification in BALB/c 3T3 cells: exposure to pH 6 followed by temperature-sensitive alkalinization during recycling. Proc Natl Acad Sci U S A (1987) 1.45
Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. Immunity (1994) 1.40
Clearance of IgE from serum of normal and hybridoma-bearing mice. J Immunol (1985) 1.30
Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis. Eur J Immunol (1994) 1.26
Cloning and expression of the neonatal rat intestinal Fc receptor, a major histocompatibility complex class I antigen homolog. Cold Spring Harb Symp Quant Biol (1989) 1.18
Intestinal transport and processing of immunoglobulin G in the neonatal and adult rat. Biol Neonate (1995) 1.17
Identification of the sites of IgG catabolism in the rat. Arch Biochem Biophys (1982) 1.13
A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthritis Rheum (1995) 1.10
Structural and phylogenetic analysis of the MHC class I-like Fc receptor gene. J Immunol (1995) 1.05
Structure and function of immunoglobulin domains. III. Isolation and characterization of a fragment corresponding to the Cgamma2 homology region of human immunoglobin G1. J Immunol (1976) 1.04
Recombinant mouse monoclonal antibodies with single amino acid substitutions affecting Clq and high affinity Fc receptor binding have identical serum half-lives in the BALB/c mouse. Mol Immunol (1992) 1.04
Transepithelial transport of maternal antibody: purification of IgG receptor from newborn rat intestine. J Immunol (1985) 0.93
Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection. Reg Immunol (1993) 0.84
Effect of protein A and its fragment B on the catabolic and Fc receptor sites of IgG. Eur J Immunol (1983) 0.83
Isotope specificity in the binding of mouse immunoglobulins to brush borders isolated from the neonatal mouse small intestine. Biochem Soc Trans (1984) 0.80
Outcome of lymphocyte subsets and cytokines during combined CD4/anti-IL-2R monoclonal antibody therapy in kidney transplantation. Transplant Proc (1995) 0.79
Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature (1990) 8.57
A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol (1993) 7.73
Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol (2010) 2.78
Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line. J Clin Invest (1999) 2.61
Nerve supply of the human knee and its functional importance. Am J Sports Med (1983) 2.59
Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med (2001) 2.57
Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med (1989) 2.41
Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab (1996) 2.37
A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J Exp Med (1994) 2.27
Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr (1998) 2.21
Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur J Immunol (1985) 2.20
Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature (1994) 2.15
Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss. Am J Transplant (2014) 2.09
Dietary trans-monounsaturated fatty acids negatively impact plasma lipids in humans: critical review of the evidence. J Am Coll Nutr (1996) 2.02
Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology (1997) 1.99
Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab (2001) 1.95
Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr (2004) 1.94
Transcytosis. Cell (1985) 1.91
Effect of vitamin A supplementation on rhodopsin mutants threonine-17 --> methionine and proline-347 --> serine in transgenic mice and in cell cultures. Proc Natl Acad Sci U S A (1998) 1.90
Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. J Immunol (1995) 1.81
Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol (2004) 1.80
Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 1.76
Expression and analysis of the polymeric immunoglobulin receptor in Madin-Darby canine kidney cells using retroviral vectors. Methods Cell Biol (1989) 1.75
Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med (2000) 1.74
A clinical trial of creatine in ALS. Neurology (2004) 1.73
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology (2006) 1.73
Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Arch Ophthalmol (2004) 1.71
Retinal degeneration associated with taurine deficiency in the cat. Science (1975) 1.69
Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol (1993) 1.67
Bidirectional transcytosis of IgG by the rat neonatal Fc receptor expressed in a rat kidney cell line: a system to study protein transport across epithelia. J Cell Sci (2000) 1.63
Maturation of postural sway in young children. Dev Med Child Neurol (1987) 1.62
The development of evidence-informed physical activity guidelines for adults with spinal cord injury. Spinal Cord (2011) 1.55
Knee joint effusion and quadriceps reflex inhibition in man. Arch Phys Med Rehabil (1984) 1.54
Mouse MHC class I-like Fc receptor encoded outside the MHC. J Immunol (1993) 1.52
Statistical considerations for pilot studies. Int J Radiat Oncol Biol Phys (1980) 1.50
Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Am J Transplant (2014) 1.44
Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules. Proc Natl Acad Sci U S A (1992) 1.44
Transepithelial transport of immunoglobulins: a model of protein sorting and transcytosis. Am J Respir Cell Mol Biol (1989) 1.42
Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med (1985) 1.41
Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium. EMBO J (1989) 1.40
Retinal degeneration in cats fed casein. I. Taurine deficiency. Invest Ophthalmol (1976) 1.39
A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J Clin Invest (1995) 1.33
Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen. Lab Invest (1986) 1.31
Global self-ratings of health and mortality: hazard in the North Carolina Piedmont. J Clin Epidemiol (1996) 1.30
Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab (2006) 1.27
Free alpha-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies. J Clin Endocrinol Metab (1999) 1.22
Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans. Nutr Metab (Lond) (2007) 1.21
Tryptophan- and dileucine-based endocytosis signals in the neonatal Fc receptor. J Biol Chem (2000) 1.20
The use of statistical MUNE in a multicenter clinical trial. Muscle Nerve (2004) 1.17
Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol (1988) 1.15
Functional outcome measures as clinical trial endpoints in ALS. Neurology (2004) 1.15
Increased urinary methylmalonic acid excretion in breast-fed infants of vegetarian mothers and identification of an acceptable dietary source of vitamin B-12. Am J Clin Nutr (1988) 1.14
Effects of mutations in potential phosphorylation sites on transcytosis of FcRn. J Cell Sci (2001) 1.11
Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas. Cancer (1983) 1.10
An ultrastructural study of nutritionally induced and reversed retinal degeneration in cats. Am J Pathol (1975) 1.10
The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (2000) 1.09
Passive visco-elastic properties of the structures spanning the human elbow joint. Eur J Appl Physiol Occup Physiol (1977) 1.07
The linoleic acid content of test diets must be carefully monitored in cholesterol studies. Am J Clin Nutr (1997) 1.07
Low bone mineral density in hormone-naïve men with prostate carcinoma. Cancer (2001) 1.06
Neck flexor muscle strength, efficiency, and relaxation times in normal subjects and subjects with unilateral neck pain and headache. Arch Phys Med Rehabil (1996) 1.05
Taurine in metabolism. Annu Rev Nutr (1981) 1.04
Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury. J Neurotrauma (1998) 1.02
Vitamin A supplementation for retinitis pigmentosa. Arch Ophthalmol (1993) 1.00
Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 1.00
Revised statistical motor unit number estimation in the Celecoxib/ALS trial. Muscle Nerve (2007) 0.99
Retinal degeneration in monkeys induced by deficiencies of vitamin E or A. Invest Ophthalmol (1974) 0.98
Role of multisite phosphorylation in the regulation of ox kidney pyruvate dehydrogenase complex. FEBS Lett (1980) 0.97
Cloning and characterization of the bovine MHC class I-like Fc receptor. J Immunol (2000) 0.96
Taurine concentrations in plasma and whole blood in humans: estimation of error from intra- and interindividual variation and sampling technique. Am J Clin Nutr (1990) 0.95
Taurine: an essential nutrient for the cat. J Nutr (1978) 0.94
Sorting signals. Curr Opin Cell Biol (1989) 0.94
Cone and rod responses in nutritionally induced retinal degeneration in the cat. Invest Ophthalmol (1973) 0.93
Bacterial biofilm formation in the urinary bladder of spinal cord injured patients. Paraplegia (1992) 0.92
Quantitative sensory testing in patients with incomplete spinal cord injury. Arch Phys Med Rehabil (1999) 0.91
Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency. J Clin Endocrinol Metab (2000) 0.91
Analysis of the promoter region of the human FcRn gene. Biochim Biophys Acta (2000) 0.91
Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting. J Appl Physiol (1985) (2001) 0.91
Monocyte adherence to endothelial cells in vitro is increased by beta-VLDL. Am J Pathol (1987) 0.91
A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer. Cancer (1981) 0.90
Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations. Neurology (2001) 0.90
Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study. Diabetes Care (1994) 0.90
On the pathophysiology of vitamin A deficiency. Nutr Rev (1971) 0.89
Dietary influence on bile acid conjugation in the cat. J Nutr (1976) 0.89
Cloning and analysis of the gene encoding the human neonatal Fc receptor. Eur J Immunogenet (2000) 0.89
Dietary palmitic and oleic acids exert similar effects on serum cholesterol and lipoprotein profiles in normocholesterolemic men and women. J Am Coll Nutr (1992) 0.89
Vitamin E supplementation suppresses prostaglandin E1(2) synthesis and enhances the immune response of aged mice. Mech Ageing Dev (1986) 0.89
LDL enhances monocyte adhesion to endothelial cells in vitro. Am J Pathol (1986) 0.89
Biomechanics of postural control. Exerc Sport Sci Rev (1982) 0.89
Suppressed anger and blood pressure: the effects of race, sex, social class, obesity, and age. Psychosom Med (1986) 0.89
Taurine requirement in primates. Nutr Rev (1985) 0.89
Pathogenesis of the optic nerve lesion in vitamin A-deficient calves. Arch Ophthalmol (1968) 0.89
An animal model of spontaneous metabolic syndrome: Nile grass rat. FASEB J (2010) 0.88
Dietary palmitic acid results in lower serum cholesterol than does a lauric-myristic acid combination in normolipemic humans. Am J Clin Nutr (1994) 0.88
Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab (1992) 0.88
Establishing evidence-based physical activity guidelines: methods for the Study of Health and Activity in People with Spinal Cord Injury (SHAPE SCI). Spinal Cord (2007) 0.88
Retinal degeneration in cats fed casein. II. Supplementation with methionine, cysteine, or taurine. Invest Ophthalmol (1976) 0.88
Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab (1998) 0.88
The fine structure of vitamin A deficiency. II. Arachnoid granulations and CSF pressure. Brain (1971) 0.88